id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-338821-khc3dqay	Zhang, Kai	Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders	2020-04-09		.txt	text/plain	503	38	45	title: Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders Many psychiatric patients have been infected with COVID-19, and patients with COVID-19 may develop psychiatric symptoms after treatment with antiviral drugs. The National Health Commission of China (NHCC) has published guidelines for treatment of COVID-19. First, many patients with psychiatric disorders have been infected with COVID-19, and second, patients with COVID-19 infections may develop a number of psychiatric symptoms, including anxiety, fear, depression and insomnia, after treatment with antiviral drugs. This is concerning because Wuhan Mental Health Center, the largest psychiatric hospital in Hubei province, reports that more than 80 staff and patients have been infected with COVID-19. 3 If a patient with psychiatric disorder is infected with COVID-19, antiviral drugs must be used in combination with psychotropic drugs, including antipsychotic, antidepressant and antianxiety drugs. If antiviral drugs are used without supplemental medication, patients with psychiatric disorders can experience relapses in their mental illness.	./cache/cord-338821-khc3dqay.txt	./txt/cord-338821-khc3dqay.txt